205 related articles for article (PubMed ID: 8519676)
21. Selective cytoprotection with amifostine in concurrent radiochemotherapy for head and neck cancer.
Büntzel J; Küttner K; Fröhlich D; Glatzel M
Ann Oncol; 1998 May; 9(5):505-9. PubMed ID: 9653491
[TBL] [Abstract][Full Text] [Related]
22. Randomized study of a short course of weekly cisplatin with or without amifostine in advanced head and neck cancer. EORTC Head and Neck Cooperative Group.
Planting AS; Catimel G; de Mulder PH; de Graeff A; Höppener F; Verweij J; Oster W; Vermorken JB
Ann Oncol; 1999 Jun; 10(6):693-700. PubMed ID: 10442192
[TBL] [Abstract][Full Text] [Related]
23. Clinical effects of amifostine (Ethyol) in patients treated with carboplatin.
Budd GT; Ganapathi R; Bukowski RM; Murthy S
Eur J Cancer; 1996; 32A Suppl 4():S43-5. PubMed ID: 8976822
[TBL] [Abstract][Full Text] [Related]
24. Concurrent chemoradiotherapy with vinorelbine and a platinum compound followed by consolidation chemotherapy for unresectable stage III non-small cell lung cancer: preliminary results of a phase II study.
Rusu P; Ciuleanu TE; Cernea D; Pelau D; Gaal V; Cebotaru C; Guttman T; Todor N; Ghilezan N
J BUON; 2007; 12(1):33-9. PubMed ID: 17436399
[TBL] [Abstract][Full Text] [Related]
25. Reduction of treatment breaks and radiation-induced esophagitis and pneumonitis using amifostine in unresectable non-small cell lung cancer patients receiving definitive concurrent chemotherapy and radiation therapy: a prospective community-based clinical trial.
Wynn RB; Mehta V
Semin Oncol; 2005 Apr; 32(2 Suppl 3):S99-104. PubMed ID: 16015543
[TBL] [Abstract][Full Text] [Related]
26. A Phase II randomized study of paclitaxel plus carboplatin or cisplatin against chemo-naive inoperable non-small cell lung cancer in the elderly.
Chen YM; Perng RP; Tsai CM; Whang-Peng J
J Thorac Oncol; 2006 Feb; 1(2):141-5. PubMed ID: 17409843
[TBL] [Abstract][Full Text] [Related]
27. Use of amifostine in the therapy of osteosarcoma in children and adolescents.
Petrilli AS; Oliveira DT; Ginani VC; Kechichian R; Dishtchekenian A; Filho Wde M; Tanaka C; Dias CG; Latorre Mdo R; Brunetto AL; Cardoso H; Almeida MT; de Camargo B
J Pediatr Hematol Oncol; 2002; 24(3):188-91. PubMed ID: 11990304
[TBL] [Abstract][Full Text] [Related]
28. Fractionated carboplatin radiosensitization: a phase I dose-escalation study.
Koukourakis MI; Stefanaki I; Giatromanolaki A; Frangiadaki C; Armenaki A; Georgoulias V; Koumandakis E; Kranidis A; Helidonis E
Am J Clin Oncol; 1998 Dec; 21(6):595-601. PubMed ID: 9856662
[TBL] [Abstract][Full Text] [Related]
29. A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial.
Ball D; Bishop J; Smith J; O'Brien P; Davis S; Ryan G; Olver I; Toner G; Walker Q; Joseph D
Radiother Oncol; 1999 Aug; 52(2):129-36. PubMed ID: 10577698
[TBL] [Abstract][Full Text] [Related]
30. Preclinical and clinical aspects on the use of amifostine as chemoprotector in neuroblastoma patients.
Fulda S; Fichtner I; Hero B; Berthold F
Med Pediatr Oncol; 2001 Jan; 36(1):199-202. PubMed ID: 11464883
[TBL] [Abstract][Full Text] [Related]
31. Double-blind randomized study on the myeloprotective effect of melatonin in combination with carboplatin and etoposide in advanced lung cancer.
Ghielmini M; Pagani O; de Jong J; Pampallona S; Conti A; Maestroni G; Sessa C; Cavalli F
Br J Cancer; 1999 Jun; 80(7):1058-61. PubMed ID: 10362116
[TBL] [Abstract][Full Text] [Related]
32. A randomized phase II study of paclitaxel with carboplatin +/- amifostine as first line treatment in advanced ovarian carcinoma.
De Vos FY; Bos AM; Schaapveld M; de Swart CA; de Graaf H; van der Zee AG; Boezen HM; de Vries EG; Willemse PH
Gynecol Oncol; 2005 Apr; 97(1):60-7. PubMed ID: 15790438
[TBL] [Abstract][Full Text] [Related]
33. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
Suntharalingam M; Jaboin J; Taylor R; Wolf J; Banglore M; Van Echo D; Ord R
Semin Oncol; 2004 Dec; 31(6 Suppl 18):2-7. PubMed ID: 15726515
[TBL] [Abstract][Full Text] [Related]
34. Administration of the cytoprotectant amifostine.
Lindemann K
Clin J Oncol Nurs; 1998 Jul; 2(3):101-4. PubMed ID: 10232150
[TBL] [Abstract][Full Text] [Related]
35. Radiochemotherapy with amifostine cytoprotection for head and neck cancer.
Büntzel J; Schuth J; Küttner K; Glatzel M
Support Care Cancer; 1998 Mar; 6(2):155-60. PubMed ID: 9540175
[TBL] [Abstract][Full Text] [Related]
36. Randomized phase II study of high-dose paclitaxel with or without amifostine in patients with metastatic breast cancer.
Gelmon K; Eisenhauer E; Bryce C; Tolcher A; Mayer L; Tomlinson E; Zee B; Blackstein M; Tomiak E; Yau J; Batist G; Fisher B; Iglesias J
J Clin Oncol; 1999 Oct; 17(10):3038-47. PubMed ID: 10506598
[TBL] [Abstract][Full Text] [Related]
37. A randomized trial of amifostine as a cytoprotective agent in patients receiving chemotherapy for small cell lung cancer.
Johnson PW; Muers MF; Peake MD; Poulter KM; Gurney EM; Napp VV; Hepburn PM; Brown JM
Br J Cancer; 2001 Jan; 84(1):19-24. PubMed ID: 11139307
[TBL] [Abstract][Full Text] [Related]
38. Phase II randomized trial comparing high-dose cisplatin with moderate-dose cisplatin and carboplatin in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party.
Sculier JP; Klastersky J; Giner V; Bureau G; Thiriaux J; Dabouis G; Efremidis A; Ries F; Berchier MC; Sergysels R
J Clin Oncol; 1994 Feb; 12(2):353-9. PubMed ID: 8113843
[TBL] [Abstract][Full Text] [Related]
39. Paclitaxel and carboplatin in the treatment of advanced non-small cell lung cancer.
Langer CJ; Leighton J; McAleer C; Comis R; O'Dwyer P; Ozols R
Semin Oncol; 1995 Jun; 22(3 Suppl 6):64-9. PubMed ID: 7541156
[TBL] [Abstract][Full Text] [Related]
40. Approaches to managing carboplatin-induced thrombocytopenia: focus on the role of amifostine.
Budd GT; Ganapathi R; Wood L; Snyder J; McLain D; Bukowski RM
Semin Oncol; 1999 Apr; 26(2 Suppl 7):41-50. PubMed ID: 10348260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
